| Application no. and date | 02791654.3 (espacenet) (Federated) (European Patent Register), 20021029 | | Patent/reg. no. and date | DK/EP 1441737, 20060809 | | Publication date | 20040804 | | Priority no. and date | US 339031 P, 20011030, US 338185 P, 20011207 | | EP pub. no. and date |
EP 1441737 20040804 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH,
DANA-FARBER CANCER INSTITUTE, INC., 44 Binney Street
Boston, MA 02115, US | | Applicant ref. no. | 127586 | | Inventor | MANLEY, Paul, William, Bruggweg 12
CH-4144 Arlesheim, CH,
GRIFFIN, James, Douglas, 156 Dean Road
Brookline, MA 02445, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/535 (2006.01) , A61K 31/55 (2006.01) , A61P 35/02 (2006.01) , C07D 487/04 (2006.01) , C07D 487/14 (2006.01) , C07D 498/22 (2006.01) , C07D 519/00 (2006.01) | | Title | Staurosporin-derivater som inhibitorer af FLT3-receptor-tyrosinkinase-aktivitet | | Int. application no. | EP2002012076 | | Int. publication no. | WO2003037347 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
